Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid
- 30 April 2005
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 146 (4), 461-468
- https://doi.org/10.1016/j.jpeds.2004.11.030
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Growth and Development of Premature Infants in Relation to ?3 and ?6 Fatty Acid StatusWorld Review of Nutrition and Dietetics, 2015
- Effect of DHA-containing formula on growth of preterm infants to 59 weeks postmenstrual ageAmerican Journal of Human Biology, 1999
- Assessment of the Efficacious Dose of Arachidonic and Docosahexaenoic Acids in Preterm Infant Formulas: Fatty Acid Composition of Erythrocyte Membrane LipidsPediatric Research, 1997
- Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasiaThe American Journal of Clinical Nutrition, 1996
- A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine monthsLipids, 1996
- A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two monthsLipids, 1996
- Visual-acuity development in healthy preterm infants: effect of marine-oil supplementationThe American Journal of Clinical Nutrition, 1993
- Arachidonic acid status correlates with first year growth in preterm infants.Proceedings of the National Academy of Sciences of the United States of America, 1993
- First year growth of preterm infants fed standard compared to marine oil n−3 supplemented formulaLipids, 1992
- Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirementsEarly Human Development, 1980